Bristol Myers Squibb’s Revlimid finally faces competition in the U.S. with Teva’s generic launch kdunleavy Mon, 03/07/2022 – […]
Ukraine pharma CEO urges the industry to rally behind his country on three fronts fkansteiner Mon, 03/07/2022 – […]
Eli Lilly, Boehringer Ingelheim’s Jardiance turns up heat on AstraZeneca’s Farxiga with broad EU heart failure approval fkansteiner […]
Bluebird Bio has ‘doubts’ about continuing to do business through 2021, announces CFO resignation kdunleavy Mon, 03/07/2022 – […]
Patients in clinical trials must undergo thorough examination in order to allow the effects of new medications to […]
McMaster inventors’ repellent wrap shown to shed all viruses and bacteria as it moves toward marketplace.
Planning the workforce is harder than guessing the number of general practitioners needed.1 We need high quality GPs. […]
bmj;376/mar07_3/o582/FAF1faCredit: John Ra, Partners in HealthPaul Farmer’s humanitarian passion was summed up in the title of the book […]
Healthcare payers, including NHS England,1 are making increasing use of outcomes based contracts for new drugs.12 Under these […]
General practice in England faces a wave of radical reform if recommendations in a new report from a […]